U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07551570) titled 'Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function' on April 20.
Brief Summary: This study is a Phase I, single-dose, open-label trial designed to evaluate the pharmacokinetics and safety of a single oral dose of 25 mg VC005 tablets in participants with renal impairment compared to participants with normal renal function.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Renal Impairment
Intervention:
DRUG: VC005 Tablets
Oral single dose
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Published by HT Digital Content ...